Diabetes
Evidence summaries and landmark trials across type 1, type 2, prevention, glycaemic control, complications, and diabetes technology.
Is Indobufen-Based Antiplatelet Therapy Consistent in Diabetic Patients After Stenting? OPTION Analysis
An OPTION post-hoc analysis finds indobufen-based antiplatelet therapy after stenting performs consistently regardless of diabetes status, with a similar bleeding advantage. PICO summary and commentary.
How Does a Text-Message Programme Support Young Adults with Type 1 Diabetes in Care Transition?
A qualitative realist evaluation finds a text-message programme supports type 1 diabetes care transition mainly via knowledge and motivation, with effects varying by individual. PICO summary and commentary.
Text Message Intervention Modestly Improves Glycemic Control in Uncontrolled T2DM: Chinese RCT
A multicentre RCT finds a 12-month text-message programme modestly improves HbA1c and blood pressure in poorly controlled type 2 diabetes, but not LDL. PICO summary and commentary.
How Do Patients Feel About Acupuncture for Diabetic Nerve Pain?
A qualitative study finds most interviewed patients describe positive experiences and symptom relief with acupuncture for diabetic neuropathy, but it cannot prove efficacy. PICO summary and commentary.
Does Enavogliflozin Improve Adipokines Independent of Weight Loss in Type 2 Diabetes?
A phase-3 secondary analysis finds enavogliflozin lowers leptin independent of weight in type 2 diabetes, while the adiponectin rise was weight-dependent. PICO summary and commentary.
Do Ultra-Processed Foods Affect Diabetes?
A cross-sectional study finds ultra-processed food intake is not linked to glucose or body size in type 2 diabetes, but is associated with higher LDL cholesterol. PICO summary and commentary.